Comments by Dr. Nathalie Cartier on the Gene Therapy Trial (VIDEO)

The StopALD Foundation

Caption

Dr. Nathalie Cartier comments on the advantages offered by gene therapy over traditional allogenic stem cell transplant. Her comments follow the successful gene therapy trial for the fatal brain disease adrenoleukodystrophy (ALD) as reported in Science. Dr. Cartier was the study's lead author where two boys were treated with a lentiviral gene therapy.

Credit

The Stop ALD Foundation

Usage Restrictions

PRESS EMBARGO TIMES: 2 p.m., US Eastern Time; 8 p.m., Central European Time, Nov. 5, 2009

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.